Christina E. McMillian

Christina E. McMillian serves as a procurement specialist responsible for managing complex acquisitions in advanced scientific and pharmaceutical domains. She plays a critical role in executing the agency’s mission to secure high-precision analytical instruments and pharmaceutical manufacturing capabilities, ensuring compliance with federal acquisition regulations and technical specifications. Her portfolio primarily encompasses capital equipment procurement, laboratory automation systems, and formulation development services, requiring deep technical evaluation and risk mitigation in highly regulated environments. McMillian’s acquisitions are characterized by rigorous requirements definition, competitive solicitation strategies, and close collaboration with technical stakeholders to align procurement outcomes with operational needs. Her contractor relationships are predominantly with large-tier manufacturers and specialized suppliers in analytical instrumentation and pharmaceutical production, reflecting the technical sophistication of the procurements she oversees. While she engages with established industry leaders in laboratory equipment and pharmaceutical processing, her contracting patterns show minimal reliance on sole-source or non-competitive awards, favoring open competition under FAR Part 15. She maintains a consistent focus on technical capability, quality assurance, and supply chain resilience, ensuring vendors meet stringent performance and compliance standards. McMillian’s set-aside preferences are overwhelmingly non-set-aside, with 95.2% of awards issued under full and open competition. However, she consistently allocates approximately 4.7% of her portfolio to small business set-asides, including 8(a) competed contracts and Total Small Business Set-Asides under FAR 19.5, demonstrating a measured but intentional commitment to socioeconomic objectives without compromising technical requirements. Her primary industry focus lies in NAICS 334516 (Analytical Laboratory Instrument Manufacturing) and 325412 (Pharmaceutical Preparation Manufacturing), reflecting deep expertise in procuring chromatography systems, mass spectrometers, sterile fill-finish equipment, and active pharmaceutical ingredient processing systems. She routinely evaluates technical proposals for compliance with cGMP, ISO 13485, and FDA validation standards, positioning her as a subject matter expert in life sciences procurement within the federal acquisition landscape.